World's Best Scientists 2026 revealed!
Xavier Anglaret

Xavier Anglaret

D-Index & Metrics

Immunology

D-Index
48
Citations
8720
World Ranking
4433
National Ranking
208

Xavier Anglaret publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Xavier Anglaret sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 223 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Xavier Anglaret D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Xavier Anglaret sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Xavier Anglaret is affiliated with the University of Bordeaux in France. Their research primarily focuses on medicine, with a concentration on infectious diseases, epidemiology, and virology, alongside interests in general health professions and nutrition and dietetics.

Their research topics cover a range of areas related to infectious diseases and public health, especially focused on HIV/AIDS and tuberculosis. These include:

  • HIV/AIDS drug development and treatment
  • HIV/AIDS research and interventions
  • HIV research and treatment
  • Tuberculosis research and epidemiology
  • Child nutrition and water access
  • Viral infections and outbreaks research
  • COVID-19 clinical research studies

Among their recent publications are the following papers, which provide insight into their research focus and contributions:

  • Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study (2021, The Lancet Global Health)
  • Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data (2020, The Lancet HIV)
  • Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults (2020, New England Journal of Medicine)
  • Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials (2020, CPT Pharmacometrics & Systems Pharmacology)
  • Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE) (2022, Clinical Microbiology and Infection)

Frequent co-authors include:

  • Anani Badjé
  • Delphine Gabillard
  • Serge Eholié
  • Christine Danel
  • Denis Malvy

Xavier Anglaret frequently publishes in:

  • SSRN Electronic Journal
  • Trials
  • The Lancet HIV
  • New England Journal of Medicine
  • International Journal of Infectious Diseases

Best Publications

  • A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

    Danel C;Moh R;Gabillard D

  • Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

    Stephen D Lawn;Anthony D Harries;Xavier Anglaret;Landon Myer

  • Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial

    Xavier Anglaret;Geneviève Chêne;Alain Attia;Siaka Toure

  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

    Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing

  • Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

    Martin W. G. Brinkhof;François Dabis;Landon Myer;David R. Bangsberg

  • Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.

    Francois Rouet;Didier K. Ekouevi;Marie-Laure Chaix;Marianne Burgard

  • Cost-effectiveness of HIV treatment in resource-poor settings - The case of Côte d'Ivoire

    Sue J. Goldie;Yazdan Yazdanpanah;Elena Losina;Milton C. Weinstein

  • CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.

    Christine Danel;Raoul Moh;Albert Minga;Amani Anzian

  • Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days.

    Boubacar Diallo;Daouda Sissoko;Nicholas J. Loman;Hadja Aïssatou Bah

  • Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.

    Siaka Toure;Bertin Kouadio;Catherine Seyler;Catherine Seyler;Moussa Traore

  • Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.

    Raoul Moh;Christine Danel;Eugène Messou;Timothée Ouassa

  • Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

    Anani Badje;Raoul Moh;Delphine Gabillard;Calixte Guéhi

  • When to Start Antiretroviral Therapy in Resource-limited Settings

    Rochelle P. Walensky;Lindsey L. Wolf;Robin Wood;Mariam O. Fofana

  • Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire.

    Armelle Pasquet;Eugène Messou;Delphine Gabillard;Albert Minga

  • Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.

    Raoul Moh;Christine Danel;Souleymane Sorho;Delphine Sauvageot

  • Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study.

    Daouda Sissoko;Sophie Duraffour;Romy Kerber;Jacques Seraphin Kolie

  • Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.

    Catherine Seyler;Siaka Toure;Eugène Messou;Dominique Bonard

  • Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.

    Catherine Seyler;Xavier Anglaret;Nicole Dakoury-Dogbo;Eugène Messou

  • AIDS and Non-AIDS Morbidity and Mortality Across the Spectrum of CD4 Cell Counts in HIV-Infected Adults Before Starting Antiretroviral Therapy in Côte d’Ivoire

    Xavier Anglaret;Albert Minga;Delphine Gabillard;Timothée Ouassa

  • Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts.

    François Dabis;Eric Balestre;Paula Braitstein;Paolo Miotti

  • Dose regimen of favipiravir for Ebola virus disease

    Anne-Marie Taburet;Anne-Marie Taburet;Jeremie Guedj;Jeremie Guedj;Xavier Anglaret

  • Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis

    Rochelle P. Walensky;Robin Wood;Andrea L. Ciaranello;A. David Paltiel

  • Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to Child

    Daouda Sissoko;Mory Keïta;Boubacar Diallo;Negar Aliabadi

  • Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with Hiv/aids in Côte d’ivoire: a trial-based analysis

    Yazdanpanah Y;Losina E;Anglaret X;Goldie Sj

  • Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire.

    Xavier Anglaret;Eugène Messou;Timothée Ouassa;Siaka Toure

Frequent Co-Authors

François Dabis
François Dabis University of Bordeaux
Kenneth A. Freedberg
Kenneth A. Freedberg Harvard University
Elena Losina
Elena Losina Brigham and Women's Hospital
Rochelle P. Walensky
Rochelle P. Walensky Harvard University
Karine Lacombe
Karine Lacombe Hôpital Saint-Antoine
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Milton C. Weinstein
Milton C. Weinstein Harvard University
Christine Rouzioux
Christine Rouzioux Necker-Enfants Malades Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology knowledge, several related online degrees offer valuable career opportunities. Many students explore Psychiatric Mental Health Nurse Practitioner roles, and identifying pmhnp programs online with best clinical placement can be crucial for gaining hands-on experience and securing employment.

Cost is often a significant consideration, so prospective students may seek out the cheapest pmhnp programs online to earn their degree without incurring heavy debt. Balancing affordability with program quality will enhance career prospects in this competitive field.

Career transitions are common in healthcare. For example, those currently working as Family Nurse Practitioners might want to specialize further, and resources explaining how to move from fnp to acute care np can provide guidance on advancing clinical skills and certifications.

Salary expectations are another key factor. Understanding how much does a dnp make in different states helps students and professionals make informed decisions about degree investment and job relocation.

Best Scientists Citing Xavier Anglaret

Trending Scientists

Recently Published Articles